Filter Results:
(10)
Show Results For
- All HBS Web (16)
- Faculty Publications (5)
Show Results For
- All HBS Web (16)
- Faculty Publications (5)
Page 1 of 10
Results
Sort by
- Summer 2021
- Article
The Cost and Evolution of Quality at Cipla Ltd, 1935–2016
By: Muhammad H. Zaman and Tarun Khanna
This article examines the evolution of Indian pharmaceutical manufacturer Cipla towards producing drugs that met the quality standards of European and U.S. regulators. It employs new research in Cipla’s corporate archives, the Creating Emerging Markets database, and... View Details
Keywords: Cipla; Pharmaceuticals; Drug Quality; Generics; Quality; Standards; Information Technology; Cost; Organizational Culture; Business History; Pharmaceutical Industry; India
Zaman, Muhammad H., and Tarun Khanna. "The Cost and Evolution of Quality at Cipla Ltd, 1935–2016." Business History Review 95, no. 2 (Summer 2021): 249–274.
- June 2003 (Revised May 2006)
- Case
Cipla
By: Rohit Deshpande and Laura Winig
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details
- April 2011 (Revised April 2015)
- Case
Cipla 2011
By: Rohit Deshpande, Sandra J. Sucher and Laura Winig
Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape. View Details
Keywords: Leadership; Leading Change; Leadership Style; Management Teams; Governance Compliance; Corporate Strategy; Pharmaceutical Industry
Deshpande, Rohit, Sandra J. Sucher, and Laura Winig. "Cipla 2011." Harvard Business School Case 511-050, April 2011. (Revised April 2015.)
- February 2007
- Supplement
Patents & Patients, CIPLA - Video
By: Rohit Deshpande
Deshpande, Rohit. "Patents & Patients, CIPLA - Video." Harvard Business School Video Supplement 507-705, February 2007.
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
business has a role to play in addressing it." For example, in one video clip, Yusuf Hamied, chairman of Mumbai-based pharmaceutical company Cipla, comments, "I'm a firm believer that if you're in the health care business like Cipla is,... View Details
Keywords: by Julia Hanna
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
unaffordable (which the pharmaceutical company Cipla did with HIV/AIDS drugs in Africa), and that brought housing to urban poor (one of building materials maker CEMEX's accomplishments in Mexico). Based on our research, we believe the... View Details
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
profitability. In Chapter 6 we describe the work of drug company Cipla in India and telephone company China Mobile working in rural western China to bring affordable drugs, and smart telephone connections, respectively, to hundreds of... View Details
Keywords: by Martha Lagace
- 21 Jun 2011
- First Look
First Look: June 21
ecosystem. Purchase this note:http://cb.hbsp.harvard.edu/cb/product/911066-PDF-ENG Cipla 2011 Rohit Deshpandé, Sandra J. Sucher, and Laura WinigHarvard Business School Case 511-050 Dr. Yusuf Hamied, head of the Indian pharma and generics... View Details
Keywords: Sean Silverthorne